Voyager Therapeutics, Inc. (VYGR) Advances Gene TherapyVoyager Therapeutics, Inc.NASDAQ:VYGRtraderspro_chartsVoyager Therapeutics, Inc. (VYGR) is a biotechnology company developing next-generation gene therapies to treat serious neurological diseases. Leveraging its TRACER capsid discovery platform, Voyager is advancing treatments for conditions like Parkinson’s disease, Huntington’s disease, and amyotrophic lateral sclerosis (ALS). The company’s growth is fueled by its innovative platform, expanding partnerships with leading pharma companies, and the rising demand for breakthrough therapies in neurology. On the chart, a confirmation bar with rising volume highlights bullish momentum. The price has entered the momentum zone after breaking above the .236 Fibonacci level. A trailing stop can be set just below this Fibonacci line using the Fibonacci snap tool, helping traders secure profits while leaving room for more upside potential.